Equity
ITCI
Intra-Cellular Therapies (ITCI)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for ITCI to draw a line in its place.
Which funds hold Intra-Cellular Therapies (ITCI)?
0 of the 45 institutional funds we track reported a Intra-Cellular Therapies position for the quarter ended 30 Jun 2025; the latest of those filings landed 14 Aug 2025.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| AQR Capital Management | Exited | |||
| Balyasny Asset Management | Exited | |||
| Citadel Advisors | Exited | |||
| D. E. Shaw & Co. | Exited | |||
| GAMCO Investors | Exited | |||
| Man Group | Exited | |||
| Marshall Wace | Exited | |||
| Millennium Management | Exited | |||
| Renaissance Technologies | Exited | |||
| Soros Fund Management | Exited |
Have members of Congress traded Intra-Cellular Therapies (ITCI)?
The most recent congressional trade disclosed in Intra-Cellular Therapies is a sale by Josh Gottheimer (house, NJ), dated 03 Apr 2025.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 03 Apr 2025 | Josh Gottheimerhouse · Democrat–NJ | Sale | 1K USD–15K USD | 41 days |
| 03 Apr 2025 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Sale | 1K USD–15K USD | 33 days |
| 24 Mar 2025 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Sale | 1K USD–15K USD | 14 days |
| 17 Mar 2025 | Josh Gottheimerhouse · Democrat–NJ | Sale | 1K USD–15K USD | 24 days |
| 24 Jan 2025 | Josh Gottheimerhouse · Democrat–NJ | Sale | 1K USD–15K USD | 17 days |
| 21 Jun 2024 | Josh Gottheimerhouse · Democrat–NJ | Sale | 1K USD–15K USD | 18 days |
| 21 Dec 2021 | Josh Gottheimerhouse · Democrat–NJ | Purchase | 1K USD–15K USD | 20 days |
| 01 May 2017 | Roger Marshallsenate · Republican–KS | Purchase | 1K USD–15K USD | 462 days |
Intra-Cellular Therapies (ITCI): frequently asked questions
Which funds own Intra-Cellular Therapies?
0 of the 45 funds we track reported a Intra-Cellular Therapies position for the quarter ended 30 Jun 2025, per their SEC Form 13F filings. The largest reported positions were AQR Capital Management, Balyasny Asset Management and Citadel Advisors. See Funds
Have members of Congress traded Intra-Cellular Therapies?
Yes. 8 trades in Intra-Cellular Therapies appear in the congressional disclosures we hold; the latest is a sale by Josh Gottheimer (House, NJ) dated 3 Apr 2025, filed 14 May 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures